Zentalis Pharmaceuticals, Inc.（ZNTL）内部人交易：高管与董事近期交易
过去 18 个月，共有 14 位内部人为 Zentalis Pharmaceuticals, Inc.（ZNTL）报告了 30 笔 Form 4 交易（最近一笔 2026-10-01）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-10-01 | Bruns Ingmar | Chief Medical Officer | 买入 | 9,727 | $21,205 |
| 2026-08-19 | WALTERS GROUP | 10% 以上股东 | 买入 | 4.3M | $15.2M |
| 2026-08-19 | WALTERS WILLIAM THURMAN | 10% 以上股东 | 买入 | 4.3M | $15.2M |
| 2026-08-19 | WALTERS SUSAN BERKLEY | 10% 以上股东 | 买入 | 4.3M | $15.2M |
| 2026-06-18 | Walker Luke Nathaniel | 董事 | 买入 | 57,100 | $0 |
| 2026-06-18 | Kariuki Enoch | 董事 | 买入 | 57,100 | $0 |
| 2026-06-18 | Johnson David Michael | 董事 | 买入 | 57,100 | $0 |
| 2026-06-18 | Skvarka Jan | 董事 | 买入 | 57,100 | $0 |
| 2026-06-18 | Myers Scott Dunseth | 董事 | 买入 | 57,100 | $0 |
| 2026-05-27 | Campbell Shannon | 董事 | 买入 | 114,200 | $0 |
| 2026-02-10 | Vultaggio Vincent | PAO and PFO | 卖出 | 29,951 | $72,781 |
| 2026-02-10 | EASTLAND JULIA MARIE | CEO & President | 卖出 | 889 | $2,125 |
| 2026-02-10 | EASTLAND JULIA MARIE | CEO & President | 卖出 | 7,866 | $19,114 |
| 2026-02-10 | Vultaggio Vincent | PAO and PFO | 卖出 | 3,379 | $8,076 |
| 2026-02-10 | Vultaggio Vincent | PAO and PFO | 卖出 | 6,894 | $16,683 |
| 2026-02-10 | Bruns Ingmar | Chief Medical Officer | 卖出 | 2,962 | $7,198 |
| 2026-02-10 | Bruns Ingmar | Chief Medical Officer | 卖出 | 335 | $801 |
| 2026-02-04 | Vultaggio Vincent | PAO and PFO | 卖出 | 2,540 | $6,477 |
| 2026-02-04 | Vultaggio Vincent | PAO and PFO | 卖出 | 556 | $1,401 |
| 2026-01-08 | WALTERS GROUP | 10% 以上股东 | 买入 | 6.5M | $7.8M |
| 2026-01-08 | WALTERS WILLIAM THURMAN | 10% 以上股东 | 买入 | 6.5M | $7.8M |
| 2026-01-08 | WALTERS SUSAN BERKLEY | 10% 以上股东 | 买入 | 6.5M | $7.8M |
| 2025-12-15 | Matrix Capital Management Company, LP | 10% 以上股东 | 卖出 | 7.5M | $10.0M |
| 2025-12-15 | GOEL DAVID E. | 10% 以上股东 | 卖出 | 7.5M | $10.0M |
| 2025-06-18 | Walker Luke Nathaniel | 董事 | 买入 | 57,603 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-10-01